Avanza Fonder Ab Biomarin Pharmaceutical Inc Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Avanza Fonder Ab holds 20,915 shares of BMRN stock, worth $1.22 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
20,915
Previous 16,156
29.46%
Holding current value
$1.22 Million
Previous $1.06 Billion
34.56%
% of portfolio
0.05%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.33MPut Options Held
968K-
Black Rock Inc. New York, NY22.7MShares$1.32 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.11 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.04 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$871 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$629 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...